A detailed history of Van Eck Associates Corp transactions in Dexcom Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 20,191 shares of DXCM stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,191
Previous 17,716 13.97%
Holding current value
$1.64 Million
Previous $2.01 Million 27.18%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$64.0 - $116.06 $158,400 - $287,248
2,475 Added 13.97%
20,191 $1.46 Million
Q2 2024

Jul 31, 2024

BUY
$110.31 - $140.45 $140,534 - $178,933
1,274 Added 7.75%
17,716 $2.01 Million
Q1 2024

Apr 30, 2024

SELL
$114.22 - $140.1 $173,271 - $212,531
-1,517 Reduced 8.45%
16,442 $2.28 Million
Q4 2023

Feb 05, 2024

SELL
$75.49 - $124.16 $201,860 - $332,003
-2,674 Reduced 12.96%
17,959 $2.23 Million
Q3 2023

Nov 08, 2023

BUY
$86.06 - $137.93 $161,534 - $258,894
1,877 Added 10.01%
20,633 $1.93 Million
Q2 2023

Aug 03, 2023

SELL
$112.47 - $130.98 $134,851 - $157,045
-1,199 Reduced 6.01%
18,756 $2.41 Million
Q1 2023

May 03, 2023

BUY
$104.0 - $122.92 $969,904 - $1.15 Million
9,326 Added 87.74%
19,955 $2.32 Million
Q4 2022

Feb 08, 2023

BUY
$84.98 - $122.67 $372,637 - $537,907
4,385 Added 70.23%
10,629 $1.2 Million
Q3 2022

Oct 27, 2022

BUY
$76.35 - $94.18 $476,729 - $588,059
6,244 New
6,244 $503,000
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $28,976 - $40,101
-308 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$129.87 - $162.82 $39,999 - $50,148
308 New
308 $165,000
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $112,007 - $138,361
-1,321 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$78.0 - $104.5 $68,718 - $92,064
881 Added 200.23%
1,321 $488,000
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $42,024 - $49,698
440 New
440 $181,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.